Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01109394 · ClinicalTrials.gov registry record
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
A clinical trial of Sarcoma and Neuroblastoma, sponsored by National Cancer Institute (NCI).
- Recruiting
- Registry status
- 6,035
- Enrollment target
- 5
- Study locations
NCT01109394: Recruiting study of Sarcoma and Neuroblastoma, sponsored by National Cancer Institute (NCI).
NCT01109394 is a study of Sarcoma and Neuroblastoma that is actively recruiting participants, run by National Cancer Institute (NCI). The registered enrollment target is 6,035 participants, above the 872-participant average among 122 other Sarcoma trials with a reported enrollment target (592% higher). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01109394, a study of Sarcoma and Neuroblastoma, is actively recruiting participants, sponsored by National Cancer Institute (NCI).
- RECRUITING
- Registry status
- 6,035 participants
- Enrollment target
- 5
- Study locations
Study Summary
Background: \- Laboratory investigators who are studying common childhood cancers are interested in developing a tissue repository to collect and store blood, serum, tissue, urine, or tumors of children who have cancer or adults who have common childhood cancers. To develop this repository, additional samples will be collected from children and adults who have been diagnosed with common childhood cancers such as leukemia and tumors of the central nervous system. Objectives: \- To collect and store blood, serum, tissue, urine, or tumor samples of children who have cancer or adults who have common childhood cancers. Eligibility: * Individuals who have been diagnosed with a common childhood cancer (e.g., leukemia) regardless of patient age. * Children, adolescents, and adults who have been diagnosed with a type of cancer more commonly found in adults. Design: * Extra blood, serum (the liquid part of blood), tissue, urine, or tumor samples will be collected from participants at a time when sampling is required for medical care or as part of a research study. * No additional procedures will be performed for the sole purpose of obtaining additional tumor tissue, aside from what is required for clinical care.
Primary Outcome
Perform systematic molecular, genomic, proteomic, metabolomics and other high throughput ( Omics ) profiling on tumor and normal tissues
Conditions Studied
Study Locations (5)
District of Columbia
- Children's National Medical Center - Washington D.C.
Florida
- Children's Hospital of Orange County (CHOC Children's) - Orange
Maryland
- National Institutes of Health Clinical Center - Bethesda
New York
- Tisch Cancer Institute, Mount Sinai Medical Center - New York
North Carolina
- Carolinas Medical Center/Levine Children's Hospital - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,035 participants |
| Start Date | 2010-04-21 |
What NCT01109394 shows while recruiting
NCT01109394 is an observational study that tracks outcomes without assigning an intervention. Its 6,035 participants enrollment target places it among the larger protocols in the corpus, above the 872-participant average among 122 other Sarcoma trials with a reported enrollment target (592% higher).
The record links to 5 conditions, with Sarcoma appearing as the primary indexed condition, and to 0 interventions.
NCT01109394 lists 5 locations in 5 states (District of Columbia, Florida, Maryland).
Frequently Asked Questions
What is clinical trial NCT01109394 about?
NCT01109394 is a clinical study titled "Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies". Background: \- Laboratory investigators who are studying common childhood cancers are interested in developing a tissue repository to collect and store blood, serum, tissue, urine, or tumors of children who have cancer or adults who have common childhood cancers. To develop this repository, additio...
What is the current status of trial NCT01109394?
This trial is currently recruiting. The enrollment target is 6,035 participants. The study started on 2010-04-21.
What conditions does trial NCT01109394 study?
This clinical trial studies the following conditions: Sarcoma, Neuroblastoma, Renal Cancer, Retinoblastoma, Endocrine Tumors.
Who is sponsoring clinical trial NCT01109394?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01109394 being conducted?
This trial has 5 study locations across District of Columbia, Florida, Maryland, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01109394's enrollment target sits among peer trials
6,035 3rd of 122 higher than 120 of 122 other Sarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
RECRUITING
-
Palbociclib and Pembrolizumab in Sarcoma
RECRUITING · Phase 1
-
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
RECRUITING
-
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Relapsed/Refractory Solid Tumors
RECRUITING · Phase 1
-
Enhanced Recovery After Surgery in Extremity Sarcoma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05884190 · 6,030 participants · NA
Trauma-informed Approach to Timely Detection and Management of Early Postpartum Hypertension
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy